Quarterly report pursuant to Section 13 or 15(d)

Other current assets (Tables)

v3.23.3
Other current assets (Tables)
9 Months Ended
Sep. 30, 2023
Other current assets  
Summary of other current assets

Other current assets consisted of the following (in thousands):

​

​

​

​

​

​

​

​

​

September 30, 

​

December 31, 

​

    

2023

    

2022

Research and development credits receivable

 

$

40,533

​

$

30,162

Prepayments

 

​

11,973

​

​

9,472

Clinical materials

 

​

1,290

​

​

1,279

VAT receivable

​

​

1,372

​

​

490

Other current assets

 

​

1,683

​

​

1,927

​

​

$

56,851

​

$

43,330

​